SCHEMBL4855199

SCHEMBL4855199

CCC(C)O[P@@](=O)(O)C(CC(=O)c1ccc(Br)cc1)NC(=O)OCC(Cl)(Cl)Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.35
▸ MAPT P10636 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ PKM P14618 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ KMT2A Q03164 4/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ FPR2 P25090 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4856863 0.91 L3MBTL1 (0.39) MAPTHPGDHTTKMT2AMEN1
SCHEMBL4845956 0.91 L3MBTL1 (0.42) ALDH1A1MAPTHPGDHTTLMNA
SCHEMBL4853494 0.90 L3MBTL1 (0.32) HTTKMT2AMEN1LMNAL3MBTL1
SCHEMBL5712076 0.90 KMT2A (0.38) ALDH1A1TDP1KMT2AMEN1
SCHEMBL4852580 0.89 KMT2A (0.38) ALDH1A1MAPTHTTHSD17B10TDP1
SCHEMBL4853708 0.87 SLC6A4 (0.39) ALDH1A1MAPTHPGDKMT2AMEN1
SCHEMBL4855188 0.82 MAPT (0.42) ALDH1A1MAPTHPGDHTTPKM
SCHEMBL4855193 0.82 MAPT (0.42) ALDH1A1MAPTHPGDHTTPKM
SCHEMBL4856627 0.81 MEN1 (0.30) KMT2AMEN1
SCHEMBL4857423 0.81 KMO (0.41) ALDH1A1MAPTHPGDHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724275-B1 PROCESS FOR PRODUCING AMINOPHOSPHONIC ACID DERIVATIVE JAPAN SCIENCE & TECH AGENCY (JP) 2015-04-08 — — EP disclosed
US-7375244-B2 Production method for aminophosphonic acid derivatives JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-05-20 — — US disclosed
US-20070142658-A1 Production method for aminophosphonic acid derivatives JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-06-21 — — US disclosed
EP-1724275-A1 PROCESS FOR PRODUCING AMINOPHOSPHONIC ACID DERIVATIVE Japan Science and Technology Agency (JP) 2006-11-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142658-A1 Production method for aminophosphonic acid derivatives AASDHPPT, NPEPPS, DAO ALDH1A1 1956/4885MAPT 3829/4885HPGD 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback